Literature DB >> 1776752

Visual function in Alzheimer's disease and normal aging.

A Cronin-Golomb1, J F Rizzo, S Corkin, J H Growdon.   

Abstract

We examined a wide range of visual behaviors in 59 patients with Alzheimer's disease (AD), 35 elderly control subjects, and 12 young control subjects. A subset of the patients with AD received neuro-ophthalmologic and electrophysiologic examinations in order to evaluate the integrity of the retino-calcarine pathway. Patients with AD showed significant, selective losses in visual function, including color discrimination, stereoacuity, contrast sensitivity, and backward masking, but not in critical flicker fusion. The deficits were not attributable to clinically apparent lesions of the retina or optic nerve. We therefore suggest that AD lesions in primary visual and posterior association cortices underlie the observed behavioral abnormalities.

Entities:  

Mesh:

Year:  1991        PMID: 1776752     DOI: 10.1111/j.1749-6632.1991.tb00186.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

1.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

2.  Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Authors:  Daniel W Wesson; Donald A Wilson; Ralph A Nixon
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 3.  Mechanisms of neural and behavioral dysfunction in Alzheimer's disease.

Authors:  Daniel W Wesson; Ralph A Nixon; Efrat Levy; Donald A Wilson
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

4.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.

Authors:  F Sartucci; D Borghetti; T Bocci; L Murri; P Orsini; V Porciatti; N Origlia; L Domenici
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

5.  Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease.

Authors:  Denise A Valenti
Journal:  Int J Alzheimers Dis       Date:  2011-01-05

6.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

Authors:  D C Davies; P McCoubrie; B McDonald; K A Jobst
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

7.  Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE.

Authors:  Nicola Origlia; Simona Capsoni; Antonino Cattaneo; Fang Fang; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.

Authors:  Shannon L Risacher; Darrell Wudunn; Susan M Pepin; Tamiko R MaGee; Brenna C McDonald; Laura A Flashman; Heather A Wishart; Heather S Pixley; Laura A Rabin; Nadia Paré; Jessica J Englert; Eben Schwartz; Joshua R Curtain; John D West; Darren P O'Neill; Robert B Santulli; Richard W Newman; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2012-10-18       Impact factor: 4.673

9.  In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease.

Authors:  Giovanni B Frisoni; Annapaola Prestia; Paul E Rasser; Matteo Bonetti; Paul M Thompson
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

10.  Roughness of retinal layers in Alzheimer's disease.

Authors:  Lucía Jáñez-García; Omar Bachtoula; Elena Salobrar-García; Rosa de Hoz; Ana I Ramirez; Pedro Gil; José M Ramirez; Luis Jáñez-Escalada
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.